Sign in
CompletedNo phase

Esophageal pH-MII Duration: 12 or 24 Hours?

Key facts

Who runs it
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
127 people enrolled
Started
13 Jul 2022
Ended
15 Feb 2025
Type of study
Observational
Treatments tested
  • multichannel intraluminal impedance and pH monitoring (MII/pH)
Record updated
11 March 2025

Who can take part

Age
1 day to 12 months
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • 24 hours MII-pH performed for suspected GER

Who cannot take part

  • previous thoraco-abdominal surgery, gastrostomy, anti-GERD therapy (thickeners, alginates, H2 blockers, proton pump inhibitor - PPIs, etc.) in the 7 days preceding the MII-pH,
  • major malformations
  • ventilatory support (invasive or non-invasive) at the time of the MII-pH

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To check whether the first 12 hours of MII-pH recording are sufficient to diagnose gastroesophageal reflux disease (GERD) among newborns/infants, with a diagnostic accuracy similar to 24 hours of recording as currently advised.

Treatments tested

  • multichannel intraluminal impedance and pH monitoring (MII/pH)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Duration of Esophageal pH-impedance Measurement in Newborns and Infants With Suspected Gastroesophageal Reflux: 12 or 24 Hours?
Publications
Record updated
11 March 2025